Prof Chang Liu | Energy metabolism | Best Researcher Award |

Prof. Chang Liu | Energy metabolism | Best Researcher Award.

China Pharmaceutical University,China

Professional Profiles:

SCOPUS

👨‍🎓 Bio Summary:

Prof. Chang Liu is the Deputy Dean, Professor, and Ph.D. Supervisor at the School of Life Science and Technology, China Pharmaceutical University. He is a distinguished researcher recognized with several national honors, including the National Excellent Youth Fund and the National High-level Talents Special Support Plan Young Top Talent. Prof. Liu’s research focuses on the molecular mechanisms of energy metabolism regulation and the pathological basis of metabolic diseases like diabetes and obesity caused by circadian rhythm disorders. He integrates traditional Chinese medicine concepts with modern Western medicine, aiming to develop targeted lead compounds and drug delivery systems. Prof. Liu has published over 150 SCI papers in prestigious journals such as Advanced Materials and Nature Communications, with an H-index of 40 and a total citation count of 5,405. His work has significantly contributed to the understanding and treatment of metabolic diseases.

🎓 Education:

Prof. Chang Liu holds a distinguished academic background with various accolades and positions. He serves as the Deputy Dean, Professor, and Ph.D. Supervisor at the School of Life Science and Technology, China Pharmaceutical University. Additionally, he is part of the 10th batch of experts assigned by the Central Organization Department to aid Xinjiang.

🔍 Research Focus:

Prof. Liu’s research explores the molecular mechanisms of energy metabolism regulation from a unique chronobiological perspective. His work aims to elucidate the pathological basis of metabolic diseases such as diabetes, fatty liver, and obesity caused by circadian rhythm disorders. Integrating traditional Chinese medicine concepts like “Zi Wu Liu Zhu,” he seeks molecular targets and gene regulatory networks connecting modern Western medicine and traditional Chinese medicine. His research also involves developing highly targeted lead compounds and drug delivery systems to treat metabolic disorders caused by circadian rhythm disturbances.

🏆 Honors & Awards:

Prof. Liu has received numerous prestigious honors, including being named a National Excellent Youth Fund recipient, a National High-level Talents Special Support Plan Young Top Talent, an Excellent Young Scientist by the Ministry of Education, and a Jiangsu Distinguished Young Scholar. He is a council member of the 13th Chinese Society for Cell Biology, a committee member of the Metabolism Professional Branch of the Chinese Society for Biochemistry and Molecular Biology, and the Vice Chairman of the Time Biomedical Professional Committee of the Chinese Society of Integrative Medicine, among other positions.

Professional Experience: 💼

In addition to his roles at China Pharmaceutical University, Prof. Liu holds several other significant positions. He is the Director of the Key Laboratory of Metabolic Inflammatory Disease Drugs in Jiangsu Province and a member of various academic committees, including the Xinjiang Endemic Disease Molecular Biology Key Laboratory and the Innovation Center for Medical Basic Research at Xinjiang Medical University.

 📚 Top Noted Publications :

Title: Gold mineralized “hybrid nanozyme bomb” for NIR-II triggered tumor effective permeation and cocktail therapy
Authors: Liu, J., He, D., Hao, T., … Xin, X., Shen, Y.
Journal: Chinese Chemical Letters
Index: 35(9)
Year: 2024
Citation: 2

Title: Specneuzhenide improves bleomycin-induced pulmonary fibrosis in mice via AMPK-dependent reduction of PD-L1
Authors: Wu, Y., Shi, W., Li, H., … Li, R., Zhang, C.
Journal: Phytomedicine
Index: 128
Year: 2024
Citation: 0

Title: A recyclable SERS-DGT device for in-situ sensing of sulfamethazine by Au@g-C3N4NS in water
Authors: Lu, Y., Li, C., Wang, Y., … Feng, Z., Sun, T.
Journal: Water Research
Index: 253
Year: 2024
Citation: 0

Title: A microthrombus-driven fixed-point cleaved nanosystem for preventing post-thrombolysis recurrence via inhibiting ferroptosis
Authors: Sun, M., Liu, C., Liu, J., … Chen, D., Shen, Y.
Journal: Journal of Controlled Release
Index: 367, pp. 587–603
Year: 2024
Citation: 0

Title: Red blood membrane camouflaging Bismuth nanoflowers designed for radio-photothermal therapy in lung cancer
Authors: Liu, C., Zhang, Y., Wen, J., … Luo, H., Zhang, H.
Journal: Journal of Drug Targeting
Index: 32(5), pp. 544–556
Year: 2024
Citation: 0

Author Metrics 📊 : 

Prof. Liu boasts an H-index of 40, reflecting the significant impact and recognition of his research contributions in the scientific community.

📅 Research Timeline:

Prof. Liu’s funded projects span various significant research initiatives. He has led projects like the National Key R&D Program sub-project on developing humanized animal models for major infectious diseases (2021-2025), the National Natural Science Foundation’s major research plan on the molecular mechanisms of liver clock and glucose-lipid metabolism integration (2021-2023), and the Jiangsu Distinguished Youth Fund project on the molecular pathology of metabolic diseases (2014-2016), among others.